<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25751622</article-id><article-id pub-id-type="pmc">4353619</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0119762</article-id><article-id pub-id-type="publisher-id">PONE-D-14-45587</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>HIF-1&#x003b1; Activation by Intermittent Hypoxia Requires NADPH Oxidase Stimulation by Xanthine Oxidase</article-title><alt-title alt-title-type="running-head">Intermittent Hypoxia and HIF-1&#x003b1; Activation by NADPH Oxidase</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nanduri</surname><given-names>Jayasri</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Vaddi</surname><given-names>Damodara Reddy</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Shakil A.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Ning</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Makarenko</surname><given-names>Vladislav</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Semenza</surname><given-names>Gregg L.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Prabhakar</surname><given-names>Nanduri R.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Institute for Integrative Physiology and Center for Systems Biology of O2 Sensing, Biological Sciences Division, University of Chicago, Chicago, Illinois, United States of America</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Vascular Program, Institute for Cell Engineering; Department of Pediatrics, Medicine, Oncology, Radiation Oncology and Biological Chemistry; and Mckusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Schr&#x000f6;der</surname><given-names>Katrin</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Goethe Universit&#x000e4;t Frankfurt, GERMANY</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: JN NRP GLS. Performed the experiments: DRV SAK NW VM. Analyzed the data: JN DRV SAK VM. Wrote the paper: JN NRP GLS.</p></fn><corresp id="cor001">* E-mail: <email>jnanduri@uchicago.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>9</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>3</issue><elocation-id>e0119762</elocation-id><history><date date-type="received"><day>10</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>16</day><month>1</month><year>2015</year></date></history><permissions><copyright-year>2015</copyright-year><copyright-holder>Nanduri et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0119762.pdf"/><abstract><p>Hypoxia-inducible factor 1 (HIF-1) mediates many of the systemic and cellular responses to intermittent hypoxia (IH), which is an experimental model that simulates O<sub>2</sub> saturation profiles occurring with recurrent apnea. IH-evoked HIF-1&#x003b1; synthesis and stability are due to increased reactive oxygen species (ROS) generated by NADPH oxidases, especially Nox2. However, the mechanisms by which IH activates Nox2 are not known. We recently reported that IH activates xanthine oxidase (XO) and the resulting increase in ROS elevates intracellular calcium levels. Since Nox2 activation requires increased intracellular calcium levels, we hypothesized XO-mediated calcium signaling contributes to Nox activation by IH. We tested this possibility in rat pheochromocytoma PC12 cells subjected to IH consisting alternating cycles of hypoxia (1.5% O<sub>2</sub> for 30 sec) and normoxia (21% O<sub>2</sub> for 5 min). Kinetic analysis revealed that IH-induced XO preceded Nox activation. Inhibition of XO activity either by allopurinol or by siRNA prevented IH-induced Nox activation, translocation of the cytosolic subunits p47<sup>phox</sup> and p67<sup>phox</sup> to the plasma membrane and their interaction with gp91<sup>phox</sup>. ROS generated by XO also contribute to IH-evoked Nox activation via calcium-dependent protein kinase C stimulation. More importantly, silencing XO blocked IH-induced upregulation of HIF-1&#x003b1; demonstrating that HIF-1&#x003b1; activation by IH requires Nox2 activation by XO.</p></abstract><funding-group><funding-statement>NRP and GLS were funded by National Institute for Health HL- -90554. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="7"/><table-count count="0"/><page-count count="12"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Sleep disordered breathing with recurrent apnea is characterized by transient (~10&#x02013;15 sec in adults) repetitive cessations of breathing, resulting in periodic decreases in arterial blood O<sub>2</sub> or intermittent hypoxia (IH). Patients with recurrent apnea develop several co-morbidities including hypertension and breathing abnormalities [<xref rid="pone.0119762.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0119762.ref002" ref-type="bibr">2</xref>]. Hypoxia-inducible factor-1 (HIF-1) is the master transcriptional activator that regulates gene expression during hypoxia [<xref rid="pone.0119762.ref003" ref-type="bibr">3</xref>]. IH activates HIF-1 mediated transcription in cell cultures and rodents [<xref rid="pone.0119762.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0119762.ref006" ref-type="bibr">6</xref>]. Mice with heterozygous deficiency of HIF-1&#x003b1; exhibit remarkable absence of IH-induced hypertension, and breathing abnormalities [<xref rid="pone.0119762.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0119762.ref006" ref-type="bibr">6</xref>], suggesting that activation of HIF-1 contributes to the cardio-respiratory abnormalities caused by IH. Analysis of the mechanisms underlying HIF-1 activation showed that IH activates NADPH oxidase (Nox), especially Nox2 [<xref rid="pone.0119762.ref007" ref-type="bibr">7</xref>]. Disruption of Nox2 function, prevents HIF-1 activation by IH in cell cultures and in mice [<xref rid="pone.0119762.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0119762.ref008" ref-type="bibr">8</xref>], suggesting that Nox2 is critical for HIF-1 activation by IH. However, the mechanism by which IH activates Nox2 has not been examined.</p><p>Nox2 is a multi-enzyme protein complex consisting of a membrane-bound gp91<sup>phox</sup> and cytosolic p67<sup>phox</sup> and p47<sup>phox</sup> subunits [<xref rid="pone.0119762.ref009" ref-type="bibr">9</xref>&#x02013;<xref rid="pone.0119762.ref011" ref-type="bibr">11</xref>]. Nox2 activation requires phosphorylation of cytosolic subunits by Ca<sup>2+</sup>-activated protein kinase C (PKC) and translocation to the membrane to form a complex with gp91<sup>phox</sup> [<xref rid="pone.0119762.ref012" ref-type="bibr">12</xref>]. We recently reported that IH activates xanthine oxidase (XO), which is a major cellular source of reactive oxygen species (ROS) [<xref rid="pone.0119762.ref013" ref-type="bibr">13</xref>]. IH-induced XO activation leads to ROS-dependent elevation of intracellular calcium ([Ca<sup>2+</sup>]<sub>i</sub>). Given that Nox2 activation critically depends on Ca<sup>2+</sup>-activated PKC [<xref rid="pone.0119762.ref014" ref-type="bibr">14</xref>], we hypothesized that [Ca<sup>2+</sup>]<sub>i</sub> elevation by XO mediates IH-induced Nox2 activation and subsequent stimulation of HIF-1. We examined this possibility in rat pheochromocytoma 12 (PC12) cell cultures exposed to IH.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and Methods</title><sec id="sec003"><title>Exposure of cell cultures to IH</title><p>PC12 cells (original clone from Dr. Lloyd Greene, Columbia University Medical Center, New York) [<xref rid="pone.0119762.ref015" ref-type="bibr">15</xref>] were cultured in Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM) supplemented with 10% horse serum, 5% fetal bovine serum (FBS), penicillin (100 U/ml), and streptomycin (100 &#x003bc;g/ml) under 10% CO<sub>2</sub> and 90% air (20% O<sub>2</sub>) at 37&#x000b0;C [<xref rid="pone.0119762.ref016" ref-type="bibr">16</xref>]. Experiments were performed on cells serum starved for 16 h in antibiotic free medium. In the experiments involving treatment with drugs, cells were pre-incubated for 30 min with either drug or vehicle. Cell cultures were exposed to IH (1.5% O<sub>2</sub> for 30 sec followed by 20% O<sub>2</sub> for 5 min at 37&#x000b0;C) as described [<xref rid="pone.0119762.ref016" ref-type="bibr">16</xref>]. Ambient O<sub>2</sub> levels in the IH chamber were monitored by an O<sub>2</sub> analyzer (Alpha Omega Instruments).</p></sec><sec id="sec004"><title>Studies with short interfering RNA (siRNA)</title><p>PC12 cells (5x10<sup>5</sup>) were plated on culture dishes coated with type IV collagen (BD Biosciences, Bedford, MA) and transfected with siRNA (Santa Cruz) targeted to XDH, gp91<sup>phox</sup> (Nox2), or a scrambled sequence at a concentration of 100 pmol/mL using DharmaFECT 2 (Dharmacon Research). Transfected cells were cultured in complete medium for 48 h before being exposed to IH.</p></sec><sec id="sec005"><title>Measurement of XO activity</title><p>Amplex Red Xanthine/Xanthine oxidase assay kit (Molecular Probes) was used to monitor to XO activity as described [<xref rid="pone.0119762.ref013" ref-type="bibr">13</xref>]. Cell lysates were incubated with a reaction mixture containing hypoxanthine, horseradish peroxidase (HRP) and Amplex Red. H<sub>2</sub>O<sub>2</sub> reacts with Amplex Red in the presence of HRP to generate the red fluorescent oxidation product resorufin. Fluorescence was measured by excitation at 530 nm and emission at 590 nm. The concentration of XO in samples was determined from a standard curve and expressed as XO mU/mg protein.</p></sec><sec id="sec006"><title>Measurement of NADPH oxidase activity</title><p>NADPH oxidase activity in the membrane-enriched protein fractions was measured by superoxide dismutase-inhibitable rate of cytochrome c reduction as described [<xref rid="pone.0119762.ref017" ref-type="bibr">17</xref>]. Briefly, the assay medium contained 100 &#x003bc;g membrane protein, 150 &#x003bc;m cytochrome c and 100 &#x003bc;m NADPH in 25 mM HEPES buffer (pH 7.0). The assay was performed in the presence and absence of superoxide dismutase (200 units/ml) at 37&#x000b0;C for 30 min. Cytochrome c reduction was measured by reading the absorbance at 550 nm. NADPH oxidase activity was calculated based on extinction coefficient [21mmol/(L)] per cm and expressed as nmol/min/mg protein.</p></sec><sec id="sec007"><title>Immunoprecipitation and Immunoblot assays</title><p>Membrane enriched fractions from PC12 cells were isolated using a plasma membrane protein extraction kit (Abcam). Briefly, cells were homogenized in the buffer mix provided and centrifuged at 700 <italic>g</italic> for 10 min at 4&#x000b0;C. The supernatant was further centrifuged at 10,000 <italic>g</italic> for 30 minutes at 4&#x000b0;C. The pellet contained the plasma membrane and cellular organelle membrane proteins. The purified membrane enriched proteins were resuspended in lysis buffer and fractionated by polyacrylamide-SDS gel electrophoresis and immunoblotted with gp91<sup>phox</sup> (sc-7663), p67<sup>phox</sup> (sc-7660) or p47<sup>phox</sup> (sc-3678) antibodies (Santa Cruz Biotechnology Inc, Dallas, USA). Antibody binding was detected using HRP-conjugated secondary antibodies followed by enhanced chemiluminescence detection system (Bio-Rad). Immunoprecipitation experiments were performed using protein A/G magnetic beads (Millipore). To detect phosphorylated p47<sup>phox</sup> and p67<sup>phox</sup>, total cell lysates were incubated with p47<sup>phox</sup> and p67<sup>phox</sup> antibodies and immune complexes were isolated using protein A/G magnetic beads. Phosphorylation of p47<sup>phox</sup> and p67<sup>phox</sup> was analyzed by immunoblots with an anti-phosphoserine antibody at a 1:500 dilution.</p></sec><sec id="sec008"><title>Measurement of PKC activity</title><p>The PKC activity was determined using an ELISA kit (Enzo Life sciences, Farmingdale, NY, USA), according to the manufacturer's instructions. Briefly, lysates from control or IH exposed cells were added to a microplate that was precoated with a PKC substrate, followed by the addition of ATP to initiate the reaction. PKC activity was determined by adding a phospho-specific substrate antibody conjugated to peroxidase and tetramethylbenzidine as a substrate. Color development, which is proportional to PKC activity was measured at 450-nm absorbance.</p></sec><sec id="sec009"><title>Measurement of [Ca<sup>2+</sup>]<sub>i</sub></title><p>Intracellular calcium levels were monitored in PC12 cells using Fura-2-AM as described previously [<xref rid="pone.0119762.ref018" ref-type="bibr">18</xref>]. Background fluorescence was subtracted from signals. Image intensity at 340 nm was divided by 380-nm image intensity to obtain the ratiometric image. Ratios were converted to free [Ca<sup>2+</sup>]<sub>i</sub> using calibration curves constructed <italic>in vitro</italic> by adding Fura-2 (50 &#x003bc;M, free acid) to solutions containing known concentrations of Ca<sup>2+</sup> (0&#x02013;2000 nM).</p></sec><sec id="sec010"><title>Statistical analysis</title><p>Data were expressed as mean &#x000b1; S.E.M from 3&#x02013;5 independent experiments with each performed in triplicate. Statistical analysis was performed by analysis of variance (ANOVA) and <italic>p</italic> values &#x0003c; 0.05 were considered significant.</p></sec></sec><sec sec-type="results" id="sec011"><title>Results</title><sec id="sec012"><title>XO mediates IH-induced Nox activation</title><p>PC12 cells were exposed to increasing cycles of IH with each cycle consisting of 30 sec of hypoxia followed by 5 min of normoxia. Analysis of the time course revealed that XO activity increased progressively with increasing number of IH cycles with a significant activation after 5 cycles, whereas Nox activation required a minimum of 10 cycles of IH (<xref rid="pone.0119762.g001" ref-type="fig">Fig. 1A</xref>). Because XO activation by IH precedes that of Nox, we hypothesized that it triggers Nox activation. To test this possibility, PC12 cells were treated with 10 &#x003bc;M allopurinol (ALLO), an inhibitor of XO and then were exposed to IH. ALLO blocked Nox activation in cells exposed to either IH<sub>10</sub> or IH<sub>60</sub> (<xref rid="pone.0119762.g001" ref-type="fig">Fig. 1B</xref>). Conversely, treating control cells with Xanthine/XO, (250 &#x003bc;M/0.01 U/mL), stimulated Nox activity and ALLO blocked this effect (<xref rid="pone.0119762.g001" ref-type="fig">Fig. 1C</xref>).</p><fig id="pone.0119762.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119762.g001</object-id><label>Fig 1</label><caption><title>XO activation is required for increased Nox activity in response to IH.</title><p>A) Time course of IH on XO and Nox activity. Squares represent significant increase in XO and Nox activity at 5 and 10 cycles of IH respectively. B) Effect of XO inhibitor, Allopurinol (ALLO; 10 &#x003bc;M) on Nox activity in PC12 cells exposed to 10 cycles (IH<sub>10</sub>) and 60 cycles (IH<sub>60</sub>) of IH or normoxia (N). C) Effect of Xanthine/XO (250 &#x003bc;M/0.01 U/mL) treatment on Nox activity under normoxic conditions with and without ALLO. Data is presented as mean &#x000b1; S.E.M from four independent experiments. ** p&#x0003c;0.01; * p&#x0003c; 0.05; ns: not significant.</p></caption><graphic xlink:href="pone.0119762.g001"/></fig><p>To further establish the role of XO, PC12 cells were transfected with small interfering RNA (siRNA) targeted to xanthine dehydrogenase (XDH), which is the precursor of XO. IH-induced XO and Nox activation were absent in cells transfected with XDH siRNA as compared with cells treated with scrambled siRNA (<xref rid="pone.0119762.g002" ref-type="fig">Fig. 2A-B</xref>).</p><fig id="pone.0119762.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119762.g002</object-id><label>Fig 2</label><caption><title>Effect of silencing XO on Nox activation.</title><p>A-B) XO and Nox activity in PC12 cells transfected with siRNA targeted against XDH, the precursor of XO or scrambled (scr) siRNA and exposed to IH<sub>10,</sub> IH<sub>60</sub> or normoxia (N). Data is presented as mean &#x000b1; S.E.M from four independent experiments. **p&#x0003c;0.01; ns: not significant.</p></caption><graphic xlink:href="pone.0119762.g002"/></fig></sec><sec id="sec013"><title>Ca<sup>2+</sup> dependent PKC activation by IH requires XO</title><p>The mechanism(s) underlying XO-dependent Nox2 activation by IH were determined. Nox2 activation requires Ca<sup>2+</sup>-dependent PKC activation [<xref rid="pone.0119762.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0119762.ref019" ref-type="bibr">19</xref>]. Cells exposed to IH<sub>10</sub> exhibited two-fold elevation in [Ca<sup>2+</sup>]<sub>i</sub> levels and this effect was blocked by ALLO (<xref rid="pone.0119762.g003" ref-type="fig">Fig. 3A</xref>). We next determined whether IH<sub>10</sub> elevated calcium levels activate PKC. In response to IH<sub>10</sub>, PKC activity increased 2.5 fold compared to control cells (P&#x0003c;0.01), and this effect was prevented by either ALLO, an inhibitor of XO; BAPTA-AM (10&#x003bc;M), a calcium chelator; or bisindolymaleimide (Bis-1; 10 &#x003bc;M), a pan PKC isoform inhibitor (<xref rid="pone.0119762.g003" ref-type="fig">Fig. 3B</xref>).</p><fig id="pone.0119762.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119762.g003</object-id><label>Fig 3</label><caption><title>XO augments Nox stimulation via Ca<sup>2+</sup> dependent PKC activation.</title><p>A) [Ca<sup>2+</sup>]i levels were monitored in PC12 cells exposed to normoxia (N) or IH<sub>10</sub> with or without ALLO treatment. B) Measurement of PKC activity in cells exposed to normoxia (N) or IH<sub>10</sub> in presence of ALLO, bisindolymaleimide (Bis-1; inhibitor of multiple PKC isoforms, 10 &#x003bc;M) or BAPTA (intracellular calcium chelator, 10 &#x003bc;M). C) Representative immunoblot showing phosphorylation of p67<sup>phox</sup> and p47<sup>phox</sup> in presence of Bis-1 and BAPTA. D) Nox activity in cells exposed to normoxia (N) or IH<sub>10</sub> in presence of BAPTA and Bis-1. Data are presented as mean &#x000b1; S.E.M. from four experiments. ** p&#x0003c; 0.01; * p&#x0003c; 0.05; ns: not significant.</p></caption><graphic xlink:href="pone.0119762.g003"/></fig></sec><sec id="sec014"><title>XO mediates IH-evoked phosphorylation and translocation of p47<sup>phox</sup> and p67<sup>phox</sup></title><p>Nox2 activation requires PKC-dependent phosphorylation and subsequent translocation of the cytosolic p47<sup>phox</sup> and p67<sup>phox</sup> subunits [<xref rid="pone.0119762.ref009" ref-type="bibr">9</xref>] to the membrane. As shown in <xref rid="pone.0119762.g003" ref-type="fig">Fig. 3C</xref>, IH-exposed cells exhibited increased levels of phosphorylated p47<sup>phox</sup> and p67<sup>phox</sup> levels. Treating cells with either BAPTA-AM or Bis-1 prevented IH-induced phosphorylation of cytosolic subunits (<xref rid="pone.0119762.g003" ref-type="fig">Fig. 3C</xref>) as well as Nox activation (<xref rid="pone.0119762.g003" ref-type="fig">Fig. 3D</xref>).</p><p>To demonstrate the translocation of the cytosolic subunits to the plasma membrane, the distribution of p67<sup>phox</sup> and p47<sup>phox</sup> proteins was analyzed in cytosolic and plasma membrane fractions of PC12 cells exposed to normoxia or IH along with gp91<sup>phox</sup>. The cytosol and membrane fractions were confirmed with the relative abundance of &#x003b1;-tubulin and pan-cadherin proteins, respectively (<xref rid="pone.0119762.g004" ref-type="fig">Fig. 4A</xref>). In normoxic cells, gp91<sup>phox</sup> was localized predominantly in the membrane fraction, whereas p67<sup>phox</sup> and p47<sup>phox</sup> were abundant in the cytosolic fraction (<xref rid="pone.0119762.g004" ref-type="fig">Fig. 4A</xref>). While IH had no effect on gp91<sup>phox</sup>, it increased p67<sup>phox</sup> and p47<sup>phox</sup> levels in the membrane fraction with concomitant reduction in the cytosolic fraction (<xref rid="pone.0119762.g004" ref-type="fig">Fig. 4A-B</xref>). Pre-treatment with ALLO prevented the effects of IH on the distribution of p67<sup>phox</sup> and p47<sup>phox</sup> proteins to the membrane (<xref rid="pone.0119762.g004" ref-type="fig">Fig. 4A-B</xref>).</p><fig id="pone.0119762.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119762.g004</object-id><label>Fig 4</label><caption><title>XO mediates IH-evoked translocation of p47<sup>phox</sup> and p67<sup>phox</sup>.</title><p>A) Representative immunoblot showing the distribution of gp91<sup>phox</sup>, p67<sup>phox</sup> and p47<sup>phox</sup> proteins in cytosolic and membrane fractions from cells exposed to normoxia (N) or IH<sub>10</sub> with or without ALLO. B) Densitometric analysis of three immunoblots presented as mean &#x000b1; S.E.M. Membrane to cytosol ratio was calculated for each protein after normalizing to tubulin and pan-cadherin respectively. Data is presented as mean &#x000b1; S.E.M from three independent experiments. ** p&#x0003c;0.01; ns: not significant.</p></caption><graphic xlink:href="pone.0119762.g004"/></fig></sec><sec id="sec015"><title>Nox2 complex formation by IH requires XO</title><p>The effect of IH on Nox2 complex formation was determined. To this end, p67<sup>phox</sup> and p47<sup>phox</sup> were immunoprecipitated and immunoblot assays were performed with anti-gp91<sup>phox</sup>, p67<sup>phox</sup> and p47<sup>phox</sup> antibodies. As shown in <xref rid="pone.0119762.g005" ref-type="fig">Fig. 5</xref>, amount of gp91<sup>phox</sup> co-immunoprecipitated with p67<sup>phox</sup> and p47<sup>phox</sup> increased in IH-exposed cells as compared to cells exposed to normoxia, indicating formation of the active Nox2 complex. Likewise, p67<sup>phox</sup> was detected in p47<sup>phox</sup> immunoprecipitates and vice versa demonstrating the association of all three subunits. Treatment with ALLO completely abolished Nox2 complex formation in cells subjected to IH (<xref rid="pone.0119762.g005" ref-type="fig">Fig. 5</xref>).</p><fig id="pone.0119762.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119762.g005</object-id><label>Fig 5</label><caption><title>Nox2 complex formation by IH requires XO.</title><p>Nox2 complex immunoprecipitated from membrane fraction of cells exposed to normoxia (N) or IH<sub>10</sub> with p67<sup>phox</sup> or p47<sup>phox</sup> antibody and analyzed for gp91<sup>phox</sup>, p67<sup>phox</sup> and p47<sup>phox</sup> proteins by immunoblot.</p></caption><graphic xlink:href="pone.0119762.g005"/></fig></sec><sec id="sec016"><title>XO contributes to HIF-1&#x003b1; upregulation by IH</title><p>Our previous studies showed that Nox2 is required for HIF-1&#x003b1; activation by IH [<xref rid="pone.0119762.ref004" ref-type="bibr">4</xref>]. The results described above demonstrate that XO mediates IH-evoked Nox activation. Therefore, we tested the effects of silencing XO activation on HIF-1&#x003b1; activation by IH<sub>.</sub> Since significant HIF-1&#x003b1; activation was seen with IH<sub>60</sub> but not IH<sub>10</sub>, HIF-1&#x003b1; protein expression was analyzed in IH<sub>60</sub> exposed cells transfected with siRNAs targeted to either XDH or gp91<sup>phox</sup>. IH-evoked HIF-1&#x003b1; activation was completely prevented in cells treated with XDH or gp91<sup>phox</sup> siRNA (<xref rid="pone.0119762.g006" ref-type="fig">Fig. 6A-B</xref>).</p><fig id="pone.0119762.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119762.g006</object-id><label>Fig 6</label><caption><title>XO contributes to HIF-1&#x003b1; upregulation by IH.</title><p>A) Top panel: Representative immunoblot showing the effects of XO silencing on HIF-1&#x003b1; protein expression in cells exposed to IH<sub>60</sub>. Bottom panel: densitometric analysis of three immunoblots presented as mean &#x000b1; S.E.M. B) Representative immunoblot showing HIF-1&#x003b1; and Nox2 expression in cells transfected with scrambled (scr) siRNA or Nox2 siRNA and exposed to normoxia (N) or IH<sub>60</sub> with or without ALLO treatment. Data are presented as mean &#x000b1; S.E.M. from four experiments. ** p &#x0003c; 0.01; ns: not significant.</p></caption><graphic xlink:href="pone.0119762.g006"/></fig></sec></sec><sec sec-type="conclusions" id="sec017"><title>Discussion</title><p>In the present study, we delineated the signaling mechanisms underlying Nox2 activation by IH. The following findings demonstrate that XO activation is the initial trigger for Nox2 activation by IH: first, IH-induced XO activation precedes Nox2; second, pharmacological blockade or genetic silencing of XO abolished Nox2 activation by IH; and third, XO activation increased Nox activity under normoxia, mimicking the effects of IH.</p><p>Our results provide insight into how XO stimulates Nox activity. In both vascular endothelial and smooth muscle cells, Nox2 activation requires translocation of the cytosolic subunits to the membrane via [Ca<sup>2+</sup>]<sub>i</sub>-activated PKC [<xref rid="pone.0119762.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0119762.ref020" ref-type="bibr">20</xref>]. Consistent with this possibility, we found that IH increases Ca<sup>2+</sup>-dependent PKC activation in PC12 cells and this effect was prevented by blockade of XO activity. More importantly, our results further demonstrated robust PKC&#x02013;dependent phosphorylation of p47<sup>phox</sup> and p67<sup>phox</sup>, and translocation to the plasma membrane in IH-exposed cells. Co-immunoprecipitation experiments provided direct evidence for Nox2 complex formation during IH, which was dependent on XO activation. PKC &#x003b1;, &#x003b2;, &#x003b4;, and &#x003b6; are all known to phosphorylate p47<sup>phox</sup> (14), whereas only PKC &#x003b6; is known to target p67<sup>phox</sup> [<xref rid="pone.0119762.ref021" ref-type="bibr">21</xref>]. Further studies are necessary to delineate the relative contribution of PKC isoforms to the phosphorylation of Nox2 cytosolic subunits during IH. Interestingly, IH<sub>10</sub> not only increased phosphorylation of p67<sup><italic>phox</italic></sup> and p47<sup>phox</sup> but also increased their relative expression. One possible explanation could be that complexing with gp91<sup>phox</sup> at the membrane or changing the phosphorylation states of the individual components may increase their stability as previously proposed [<xref rid="pone.0119762.ref020" ref-type="bibr">20</xref>]. Pharmacological treatments that inhibited the subunits from translocating to the membrane also prevented their increased expression, supporting the proposed hypothesis. Further investigation is required to confirm this model. An important finding of this study is that IH-induced XO activity also contributes to increased levels of HIF-1&#x003b1;. We previously reported that IH-evoked HIF-2&#x003b1; degradation is mediated by Ca<sup>2+</sup>-dependent calpain activation via XO-generated ROS [<xref rid="pone.0119762.ref013" ref-type="bibr">13</xref>]. Current results demonstrate that the same Ca<sup>2+</sup> signaling triggered by XO also mediates IH-evoked HIF-1&#x003b1; activation by stimulating Nox2. XO activation by IH is mediated by proteolytic conversion of XDH to XO which is blocked by inhibiting proteolysis with a trypsin inhibitor [<xref rid="pone.0119762.ref013" ref-type="bibr">13</xref>]. These findings are reminiscent of an early study showing that XDH can be converted to XO within minutes in response to ischemia [<xref rid="pone.0119762.ref022" ref-type="bibr">22</xref>] and suggests that similar rapid proteolytic conversion of XDH to XO during the initial cycles of the IH paradigm may play a regulatory role in triggering Nox2 activation. Previous studies with ischemia re-perfusion models showed that XO gets activated during the re-oxygenation phase rather than during ischemia. Similar to ischemia-reperfusion, IH is associated with alternating cycles of hypoxia and re-oxygenation. Since such re-oxygenation periods are absent during sustained hypoxia, we believe XO-NOX-HIF-&#x003b1; pathway is selective to IH.</p><p>It was proposed that increased generation of ROS mediates the pathological effects of IH [<xref rid="pone.0119762.ref023" ref-type="bibr">23</xref>]. Indeed, ROS levels were elevated in the carotid body [<xref rid="pone.0119762.ref024" ref-type="bibr">24</xref>], adrenal medulla [<xref rid="pone.0119762.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0119762.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0119762.ref026" ref-type="bibr">26</xref>] and central nervous system [<xref rid="pone.0119762.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0119762.ref028" ref-type="bibr">28</xref>] of rats and mice exposed to chronic IH. Remarkably, the effects of IH on catecholamine secretion, blood pressure elevation, long-term facilitation of respiratory motor activity, and sensory long-term facilitation in the carotid body can all be blocked by treating rodents with a ROS scavenger [<xref rid="pone.0119762.ref029" ref-type="bibr">29</xref>&#x02013;<xref rid="pone.0119762.ref033" ref-type="bibr">33</xref>]. Obstructive sleep apnea patients exhibit elevated ROS levels [<xref rid="pone.0119762.ref034" ref-type="bibr">34</xref>&#x02013;<xref rid="pone.0119762.ref036" ref-type="bibr">36</xref>] with impaired vasodilation, and antioxidant treatment restores the vascular responses [<xref rid="pone.0119762.ref037" ref-type="bibr">37</xref>]. These studies suggest that ROS play a critical role in mediating the cardiovascular pathology associated with IH. We previously reported that IH increases HIF-1&#x003b1; and decreases HIF-2&#x003b1; protein levels [<xref rid="pone.0119762.ref025" ref-type="bibr">25</xref>]. HIF-1 mediates transcriptional activation of Nox2, a pro-oxidant, whereas HIF-2 is a potent activator of genes encoding anti-oxidants including superoxide dismutase-2 [<xref rid="pone.0119762.ref038" ref-type="bibr">38</xref>]. Taken together, results from the current and previous studies, it is likely that XO-dependent ROS mediates imbalance between HIF-1 and HIF-2 via Nox2 and calpain activation, which leads to further long-lasting oxidative stress during IH that results in autonomic morbidities as summarized in <xref rid="pone.0119762.g007" ref-type="fig">Fig. 7</xref>.</p><fig id="pone.0119762.g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119762.g007</object-id><label>Fig 7</label><caption><title>Schematic representation of feed-forward ROS-induced ROS mechanism by XO during IH.</title><p>Exposing PC12 cells to IH<sub>10</sub> activates XO, which triggers a series of events that lead to more persistent ROS production by increasing NOX and calpain activity and causes an imbalance in the HIFs that favors transactivation of pro-oxidant enzymes over anti-oxidant ones. Increased ROS levels lead to breathing abnormalities and hypertension.</p></caption><graphic xlink:href="pone.0119762.g007"/></fig></sec></body><back><ref-list><title>References</title><ref id="pone.0119762.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Nieto</surname><given-names>FJ</given-names></name>, <name><surname>Young</surname><given-names>TB</given-names></name>, <name><surname>Lind</surname><given-names>BK</given-names></name>, <name><surname>Shahar</surname><given-names>E</given-names></name>, <name><surname>Samet</surname><given-names>JM</given-names></name>, <name><surname>Redline</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study</article-title>. <source>JAMA</source>. <year>2000</year>;<volume>283</volume>(<issue>14</issue>):<fpage>1829</fpage>&#x02013;<lpage>1836</lpage>
<object-id pub-id-type="pmid">10770144</object-id><pub-id pub-id-type="pmid">10770144</pub-id></mixed-citation></ref><ref id="pone.0119762.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Young</surname><given-names>T</given-names></name>, <name><surname>Finn</surname><given-names>L</given-names></name>, <name><surname>Peppard</surname><given-names>PE</given-names></name>, <name><surname>Szklo-Coxe</surname><given-names>M</given-names></name>, <name><surname>Austin</surname><given-names>D</given-names></name>, <name><surname>Nieto</surname><given-names>FJ</given-names></name>, <etal>et al</etal>
<article-title>Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort</article-title>. <source>Sleep</source>. <year>2008</year>;<volume>31</volume>(<issue>8</issue>):<fpage>1071</fpage>&#x02013;<lpage>1078</lpage>
<object-id pub-id-type="pmid">18714778</object-id><pub-id pub-id-type="pmid">18714778</pub-id></mixed-citation></ref><ref id="pone.0119762.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Prabhakar</surname><given-names>NR</given-names></name>, <name><surname>Semenza</surname><given-names>GL</given-names></name>
<article-title>Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2</article-title>. <source>Physiol Rev</source>. <year>2012</year>;<volume>92</volume>(<issue>3</issue>):<fpage>967</fpage>&#x02013;<lpage>1003</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/physrev.00030.2011">10.1152/physrev.00030.2011</ext-link></comment><object-id pub-id-type="pmid">22811423</object-id><pub-id pub-id-type="pmid">22811423</pub-id></mixed-citation></ref><ref id="pone.0119762.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>G</given-names></name>, <name><surname>Nanduri</surname><given-names>J</given-names></name>, <name><surname>Khan</surname><given-names>S</given-names></name>, <name><surname>Semenza</surname><given-names>GL</given-names></name>, <name><surname>Prabhakar</surname><given-names>NR</given-names></name>
<article-title>Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR</article-title>. <source>J Cell Physiol</source>. <year>2008</year>;<volume>217</volume>(<issue>3</issue>):<fpage>674</fpage>&#x02013;<lpage>685</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/jcp.21537">10.1002/jcp.21537</ext-link></comment><object-id pub-id-type="pmid">18651560</object-id><pub-id pub-id-type="pmid">18651560</pub-id></mixed-citation></ref><ref id="pone.0119762.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Peng</surname><given-names>YJ</given-names></name>, <name><surname>Yuan</surname><given-names>G</given-names></name>, <name><surname>Ramakrishnan</surname><given-names>D</given-names></name>, <name><surname>Sharma</surname><given-names>SD</given-names></name>, <name><surname>Bosch-Marce</surname><given-names>M</given-names></name>, <name><surname>Kumar</surname><given-names>GK</given-names></name>, <etal>et al</etal>
<article-title>Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia</article-title>. <source>J Physiol</source>. <year>2006</year>;<volume>577</volume>(Pt <issue>2</issue>):<fpage>705</fpage>&#x02013;<lpage>716</lpage>
<object-id pub-id-type="pmid">16973705</object-id><pub-id pub-id-type="pmid">16973705</pub-id></mixed-citation></ref><ref id="pone.0119762.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Prabhakar</surname><given-names>NR</given-names></name>, <name><surname>Kumar</surname><given-names>GK</given-names></name>, <name><surname>Nanduri</surname><given-names>J</given-names></name>
<article-title>Intermittent hypoxia augments acute hypoxic sensing via HIF-mediated ROS</article-title>. <source>Respir Physiol Neurobiol</source>. <year>2010</year>;<volume>174</volume>(<issue>3</issue>):<fpage>230</fpage>&#x02013;<lpage>234</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.resp.2010.08.022">10.1016/j.resp.2010.08.022</ext-link></comment><object-id pub-id-type="pmid">20804864</object-id><pub-id pub-id-type="pmid">20804864</pub-id></mixed-citation></ref><ref id="pone.0119762.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>G</given-names></name>, <name><surname>Khan</surname><given-names>SA</given-names></name>, <name><surname>Luo</surname><given-names>W</given-names></name>, <name><surname>Nanduri</surname><given-names>J</given-names></name>, <name><surname>Semenza</surname><given-names>GL</given-names></name>, <name><surname>Prabhakar</surname><given-names>NR</given-names></name>
<article-title>Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia</article-title>. <source>J Cell Physiol</source>. <year>2011</year>;<volume>226</volume>(<issue>11</issue>):<fpage>2925</fpage>&#x02013;<lpage>233</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/jcp.22640">10.1002/jcp.22640</ext-link></comment><object-id pub-id-type="pmid">21302291</object-id><pub-id pub-id-type="pmid">21302291</pub-id></mixed-citation></ref><ref id="pone.0119762.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Peng</surname><given-names>YJ</given-names></name>, <name><surname>Nanduri</surname><given-names>J</given-names></name>, <name><surname>Yuan</surname><given-names>G</given-names></name>, <name><surname>Wang</surname><given-names>N</given-names></name>, <name><surname>Deneris</surname><given-names>E</given-names></name>, <name><surname>Pendyala</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia</article-title>. <source>J Neurosci</source>. <year>2009</year>;<volume>29</volume>(<issue>15</issue>):<fpage>4903</fpage>&#x02013;<lpage>4910</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1523/JNEUROSCI.4768-08.2009">10.1523/JNEUROSCI.4768-08.2009</ext-link></comment><object-id pub-id-type="pmid">19369559</object-id><pub-id pub-id-type="pmid">19369559</pub-id></mixed-citation></ref><ref id="pone.0119762.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Block</surname><given-names>K</given-names></name>, <name><surname>Gorin</surname><given-names>Y</given-names></name>
<article-title>Aiding and abetting roles of NOX oxidases in cellular transformation</article-title>. <source>Nat Rev Cancer</source>. <year>2012</year>;<volume>12</volume>(<issue>9</issue>):<fpage>627</fpage>&#x02013;<lpage>637</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrc3339">10.1038/nrc3339</ext-link></comment><object-id pub-id-type="pmid">22918415</object-id><pub-id pub-id-type="pmid">22918415</pub-id></mixed-citation></ref><ref id="pone.0119762.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Leto</surname><given-names>TL</given-names></name>, <name><surname>Morand</surname><given-names>S</given-names></name>, <name><surname>Hurt</surname><given-names>D</given-names></name>, <name><surname>Ueyama</surname><given-names>T</given-names></name>
<article-title>Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases</article-title>. <source>Antioxid Redox Signal</source>. <year>2009</year>;<volume>11</volume>(<issue>10</issue>):<fpage>2607</fpage>&#x02013;<lpage>2619</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/ARS.2009.2637">10.1089/ARS.2009.2637</ext-link></comment><object-id pub-id-type="pmid">19438290</object-id><pub-id pub-id-type="pmid">19438290</pub-id></mixed-citation></ref><ref id="pone.0119762.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Bedard</surname><given-names>K</given-names></name>, <name><surname>Krause</surname><given-names>KH</given-names></name>
<article-title>The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology</article-title>. <source>Physiol Rev</source>. <year>2007</year>;<volume>87</volume>(<issue>1</issue>):<fpage>245</fpage>&#x02013;<lpage>313</lpage>
<object-id pub-id-type="pmid">17237347</object-id><pub-id pub-id-type="pmid">17237347</pub-id></mixed-citation></ref><ref id="pone.0119762.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Rotrosen</surname><given-names>D</given-names></name>, <name><surname>Leto</surname><given-names>TL</given-names></name>
<article-title>Phosphorylation of neutrophil 47-kDa cytosolic oxidase factor. Translocation to membrane is associated with distinct phosphorylation events</article-title>. <source>J Biol Chem</source>. <year>1990</year>;<volume>265</volume>(<issue>32</issue>):<fpage>19910</fpage>&#x02013;<lpage>19915</lpage>
<object-id pub-id-type="pmid">2246268</object-id><pub-id pub-id-type="pmid">2246268</pub-id></mixed-citation></ref><ref id="pone.0119762.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Nanduri</surname><given-names>J</given-names></name>, <name><surname>Vaddi</surname><given-names>DR</given-names></name>, <name><surname>Khan</surname><given-names>SA</given-names></name>, <name><surname>Wang</surname><given-names>N</given-names></name>, <name><surname>Makerenko</surname><given-names>V</given-names></name>, <name><surname>Prabhakar</surname><given-names>NR</given-names></name>
<article-title>Xanthine oxidase mediates hypoxia-inducible factor-2&#x003b1; degradation by intermittent hypoxia</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>10</issue>):<fpage>e75838</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0075838">10.1371/journal.pone.0075838</ext-link></comment><object-id pub-id-type="pmid">24124516</object-id><pub-id pub-id-type="pmid">24124516</pub-id></mixed-citation></ref><ref id="pone.0119762.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Fontayne</surname><given-names>A</given-names></name>, <name><surname>Dang</surname><given-names>PM</given-names></name>, <name><surname>Gougerot-Pocidalo</surname><given-names>MA</given-names></name>, <name><surname>El-Benna</surname><given-names>J</given-names></name>
<article-title>Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation</article-title>. <source>Biochemistry</source>. <year>2002</year>;<volume>41</volume>(<issue>24</issue>):<fpage>7743</fpage>&#x02013;<lpage>7750</lpage>
<object-id pub-id-type="pmid">12056906</object-id><pub-id pub-id-type="pmid">12056906</pub-id></mixed-citation></ref><ref id="pone.0119762.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>G</given-names></name>, <name><surname>Adhikary</surname><given-names>G</given-names></name>, <name><surname>McCormick</surname><given-names>AA</given-names></name>, <name><surname>Holcroft</surname><given-names>JJ</given-names></name>, <name><surname>Kumar</surname><given-names>GK</given-names></name>, <name><surname>Prabhakar</surname><given-names>NR</given-names></name>
<article-title>Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells</article-title>. <source>J Physiol</source>. <year>2004</year>;<volume>557</volume>(Pt <issue>3</issue>):<fpage>773</fpage>&#x02013;<lpage>783</lpage>
<object-id pub-id-type="pmid">15107478</object-id><pub-id pub-id-type="pmid">15107478</pub-id></mixed-citation></ref><ref id="pone.0119762.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>G</given-names></name>, <name><surname>Nanduri</surname><given-names>J</given-names></name>, <name><surname>Bhasker</surname><given-names>CR</given-names></name>, <name><surname>Semenza</surname><given-names>GL</given-names></name>, <name><surname>Prabhakar</surname><given-names>NR</given-names></name>
<article-title>Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia</article-title>. <source>J Biol Chem</source>. <year>2005</year>;<volume>280</volume>(<issue>6</issue>):<fpage>4321</fpage>&#x02013;<lpage>4328</lpage>
<object-id pub-id-type="pmid">15569687</object-id><pub-id pub-id-type="pmid">15569687</pub-id></mixed-citation></ref><ref id="pone.0119762.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>SA</given-names></name>, <name><surname>Nanduri</surname><given-names>J</given-names></name>, <name><surname>Yuan</surname><given-names>G</given-names></name>, <name><surname>Kinsman</surname><given-names>B</given-names></name>, <name><surname>Kumar</surname><given-names>GK</given-names></name>, <name><surname>Joseph</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>NADPH oxidase 2 mediates intermittent hypoxia-induced mitochondrial complex I inhibition: relevance to blood pressure changes in rats</article-title>. <source>Antioxid Redox Signal</source>. <year>2011</year>;<volume>14</volume>(<issue>4</issue>):<fpage>533</fpage>&#x02013;<lpage>542</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/ars.2010.3213">10.1089/ars.2010.3213</ext-link></comment><object-id pub-id-type="pmid">20618070</object-id><pub-id pub-id-type="pmid">20618070</pub-id></mixed-citation></ref><ref id="pone.0119762.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Makarenko</surname><given-names>VV</given-names></name>, <name><surname>Nanduri</surname><given-names>J</given-names></name>, <name><surname>Raghuraman</surname><given-names>G</given-names></name>, <name><surname>Fox</surname><given-names>AP</given-names></name>, <name><surname>Gadalla</surname><given-names>MM</given-names></name>, <name><surname>Kumar</surname><given-names>GK</given-names></name>, <etal>et al</etal>
<article-title>Endogenous H2S is required for Hypoxic Sensing by Carotid Body Glomus Cells</article-title>. <source>Am J Physiol Cell Physiol</source>. <year>2012</year>;<volume>301</volume>(<issue>9</issue>):<fpage>C916</fpage>&#x02013;<lpage>923</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/ajpcell.00100.2012">10.1152/ajpcell.00100.2012</ext-link></comment><object-id pub-id-type="pmid">22744006</object-id><pub-id pub-id-type="pmid">22744006</pub-id></mixed-citation></ref><ref id="pone.0119762.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Cosentino-Gomes</surname><given-names>D</given-names></name>, <name><surname>Rocco-Machado</surname><given-names>N</given-names></name>, <name><surname>Meyer-Fernandes</surname><given-names>JR</given-names></name>
<article-title>Cell Signaling through Protein Kinase C Oxidation and Activation</article-title>. <source>Int J Mol Sci</source>. <year>2012</year>;<volume>13</volume>(<issue>9</issue>):<fpage>10697</fpage>&#x02013;<lpage>10721</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3390/ijms130910697">10.3390/ijms130910697</ext-link></comment><object-id pub-id-type="pmid">23109817</object-id><pub-id pub-id-type="pmid">23109817</pub-id></mixed-citation></ref><ref id="pone.0119762.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>JM</given-names></name>, <name><surname>Shah</surname><given-names>AM</given-names></name>
<article-title>Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells</article-title>. <source>J Biol Chem</source>. <year>2002</year>;<volume>277</volume>(<issue>22</issue>):<fpage>19952</fpage>&#x02013;<lpage>19960</lpage>
<object-id pub-id-type="pmid">11893732</object-id><pub-id pub-id-type="pmid">11893732</pub-id></mixed-citation></ref><ref id="pone.0119762.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>X</given-names></name>, <name><surname>Xu</surname><given-names>B</given-names></name>, <name><surname>Bhattacharjee</surname><given-names>A</given-names></name>, <name><surname>Oldfield</surname><given-names>CM</given-names></name>, <name><surname>Wientjes</surname><given-names>FB</given-names></name>, <name><surname>Feldman</surname><given-names>GM</given-names></name>, <etal>et al</etal>
<article-title>Protein kinase Cdelta regulates p67phox phosphorylation in human monocytes</article-title>. <source>J Leukoc Biol</source>. <year>2005</year>;<volume>77</volume>(<issue>3</issue>):<fpage>414</fpage>&#x02013;<lpage>420</lpage>
<object-id pub-id-type="pmid">15591124</object-id><pub-id pub-id-type="pmid">15591124</pub-id></mixed-citation></ref><ref id="pone.0119762.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Parks</surname><given-names>DA</given-names></name>, <name><surname>Granger</surname><given-names>DN</given-names></name>, <name><surname>Bulkley</surname><given-names>GB</given-names></name>, <name><surname>Shah</surname><given-names>AK</given-names></name>
<article-title>Soybean trypsin inhibitor attenuates ischemic injury to the feline small intestine</article-title>. <source>Gastroenterology</source>. <year>1985</year>;<volume>89</volume>(<issue>1</issue>):<fpage>6</fpage>&#x02013;<lpage>12</lpage>
<object-id pub-id-type="pmid">4007413</object-id><pub-id pub-id-type="pmid">4007413</pub-id></mixed-citation></ref><ref id="pone.0119762.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Prabhakar</surname><given-names>NR</given-names></name>, <name><surname>Kumar</surname><given-names>GK</given-names></name>, <name><surname>Nanduri</surname><given-names>J</given-names></name>, <name><surname>Semenza</surname><given-names>GL</given-names></name>
<article-title>ROS signaling in systemic and cellular responses to chronic intermittent hypoxia</article-title>. <source>Antioxid Redox Signal</source>. <year>2007</year>;<volume>9</volume>(<issue>9</issue>):<fpage>1397</fpage>&#x02013;<lpage>1403</lpage>
<object-id pub-id-type="pmid">17627465</object-id><pub-id pub-id-type="pmid">17627465</pub-id></mixed-citation></ref><ref id="pone.0119762.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Prabhakar</surname><given-names>NR</given-names></name>, <name><surname>Peng</surname><given-names>YJ</given-names></name>, <name><surname>Kumar</surname><given-names>GK</given-names></name>, <name><surname>Pawar</surname><given-names>A</given-names></name>
<article-title>Altered carotid body function by intermittent hypoxia in neonates and adults: relevance to recurrent apneas</article-title>. <source>Respir Physiol Neurobiol</source>. <year>2007</year>;<volume>157</volume>(<issue>1</issue>):<fpage>148</fpage>&#x02013;<lpage>153</lpage>
<object-id pub-id-type="pmid">17317339</object-id><pub-id pub-id-type="pmid">17317339</pub-id></mixed-citation></ref><ref id="pone.0119762.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Nanduri</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>N</given-names></name>, <name><surname>Yuan</surname><given-names>G</given-names></name>, <name><surname>Khan</surname><given-names>SA</given-names></name>, <name><surname>Souvannakitti</surname><given-names>D</given-names></name>, <name><surname>Peng</surname><given-names>YJ</given-names></name>, <etal>et al</etal>
<article-title>Intermittent hypoxia degrades HIF-2alpha via calpains resulting in oxidative stress: implications for recurrent apnea-induced morbidities</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2009</year>;<volume>106</volume>(<issue>4</issue>):<fpage>1199</fpage>&#x02013;<lpage>1204</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0811018106">10.1073/pnas.0811018106</ext-link></comment><object-id pub-id-type="pmid">19147445</object-id><pub-id pub-id-type="pmid">19147445</pub-id></mixed-citation></ref><ref id="pone.0119762.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>GK</given-names></name>, <name><surname>Rai</surname><given-names>V</given-names></name>, <name><surname>Sharma</surname><given-names>SD</given-names></name>, <name><surname>Ramakrishnan</surname><given-names>DP</given-names></name>, <name><surname>Peng</surname><given-names>YJ</given-names></name>, <name><surname>Souvannakitti</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress</article-title>. <source>J Physiol</source>. <year>2006</year>;<volume>575</volume>(Pt <issue>1</issue>):<fpage>229</fpage>&#x02013;<lpage>239</lpage>
<object-id pub-id-type="pmid">16777938</object-id><pub-id pub-id-type="pmid">16777938</pub-id></mixed-citation></ref><ref id="pone.0119762.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Raghuraman</surname><given-names>G</given-names></name>, <name><surname>Rai</surname><given-names>V</given-names></name>, <name><surname>Peng</surname><given-names>YJ</given-names></name>, <name><surname>Prabhakar</surname><given-names>NR</given-names></name>, <name><surname>Kumar</surname><given-names>GK</given-names></name>
<article-title>Pattern-specific sustained activation of tyrosine hydroxylase by intermittent hypoxia: role of reactive oxygen species-dependent downregulation of protein phosphatase 2A and upregulation of protein kinases</article-title>. <source>Antioxid Redox Signal</source>. <year>2009</year>;<volume>11</volume>(<issue>8</issue>):<fpage>1777</fpage>&#x02013;<lpage>1789</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/ARS.2008.2368">10.1089/ARS.2008.2368</ext-link></comment><object-id pub-id-type="pmid">19335094</object-id><pub-id pub-id-type="pmid">19335094</pub-id></mixed-citation></ref><ref id="pone.0119762.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Sharma</surname><given-names>SD</given-names></name>, <name><surname>Raghuraman</surname><given-names>G</given-names></name>, <name><surname>Lee</surname><given-names>MS</given-names></name>, <name><surname>Prabhakar</surname><given-names>NR</given-names></name>, <name><surname>Kumar</surname><given-names>GK</given-names></name>
<article-title>Intermittent hypoxia activates peptidylglycine alpha-amidating monooxygenase in rat brain stem via reactive oxygen species-mediated proteolytic processing</article-title>. <source>J Appl Physiol</source>. <year>2009</year>;<volume>106</volume>(<issue>1</issue>):<fpage>12</fpage>&#x02013;<lpage>9</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/japplphysiol.90702.2008">10.1152/japplphysiol.90702.2008</ext-link></comment><object-id pub-id-type="pmid">18818385</object-id><pub-id pub-id-type="pmid">18818385</pub-id></mixed-citation></ref><ref id="pone.0119762.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Troncoso Brindeiro</surname><given-names>CM</given-names></name>, <name><surname>da Silva</surname><given-names>AQ</given-names></name>, <name><surname>Allahdadi</surname><given-names>KJ</given-names></name>, <name><surname>Youngblood</surname><given-names>V</given-names></name>, <name><surname>Kanagy</surname><given-names>NL</given-names></name>
<article-title>Reactive oxygen species contribute to sleep apnea-induced hypertension in rats</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2007</year>;<volume>293</volume>(<issue>5</issue>):<fpage>H2971</fpage>&#x02013;<lpage>2976</lpage>
<object-id pub-id-type="pmid">17766485</object-id><pub-id pub-id-type="pmid">17766485</pub-id></mixed-citation></ref><ref id="pone.0119762.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Peng</surname><given-names>YJ</given-names></name>, <name><surname>Prabhakar</surname><given-names>NR</given-names></name>
<article-title>Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia</article-title>. <source>J Appl Physiol</source>. <year>2003</year>;<volume>94</volume>(<issue>6</issue>):<fpage>2342</fpage>&#x02013;<lpage>2349</lpage>
<object-id pub-id-type="pmid">12533494</object-id><pub-id pub-id-type="pmid">12533494</pub-id></mixed-citation></ref><ref id="pone.0119762.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Prabhakar</surname><given-names>NR</given-names></name>, <name><surname>Peng</surname><given-names>YJ</given-names></name>, <name><surname>Yuan</surname><given-names>G</given-names></name>, <name><surname>Kumar</surname><given-names>GK</given-names></name>
<article-title>Reactive oxygen species facilitate oxygen sensing</article-title>. <source>Novartis Found Symp</source>. <year>2006</year>;<volume>272</volume>:<fpage>95</fpage>&#x02013;<lpage>9</lpage>; discussion 100&#x02013;5, 31&#x02013;40. <object-id pub-id-type="pmid">16686431</object-id><pub-id pub-id-type="pmid">16686431</pub-id></mixed-citation></ref><ref id="pone.0119762.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Kuri</surname><given-names>BA</given-names></name>, <name><surname>Khan</surname><given-names>SA</given-names></name>, <name><surname>Chan</surname><given-names>SA</given-names></name>, <name><surname>Prabhakar</surname><given-names>NR</given-names></name>, <name><surname>Smith</surname><given-names>CB</given-names></name>
<article-title>Increased secretory capacity of mouse adrenal chromaffin cells by chronic intermittent hypoxia: involvement of protein kinase C</article-title>. <source>J Physiol</source>. <year>2007</year>;<volume>584</volume>(Pt <issue>1</issue>):<fpage>313</fpage>&#x02013;<lpage>319</lpage>.<pub-id pub-id-type="pmid">17702812</pub-id></mixed-citation></ref><ref id="pone.0119762.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Souvannakitti</surname><given-names>D</given-names></name>, <name><surname>Kumar</surname><given-names>GK</given-names></name>, <name><surname>Fox</surname><given-names>A</given-names></name>, <name><surname>Prabhakar</surname><given-names>NR</given-names></name>
<article-title>Neonatal intermittent hypoxia leads to long-lasting facilitation of acute hypoxia-evoked catecholamine secretion from rat chromaffin cells</article-title>. <source>J Neurophysiol</source>. <year>2009</year>;<volume>101</volume>(<issue>6</issue>):<fpage>2837</fpage>&#x02013;<lpage>2846</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/jn.00036.2009">10.1152/jn.00036.2009</ext-link></comment><object-id pub-id-type="pmid">19339466</object-id><pub-id pub-id-type="pmid">19339466</pub-id></mixed-citation></ref><ref id="pone.0119762.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Dyugovskaya</surname><given-names>L</given-names></name>, <name><surname>Lavie</surname><given-names>P</given-names></name>, <name><surname>Lavie</surname><given-names>L</given-names></name>
<article-title>Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2002</year>;<volume>165</volume>(<issue>7</issue>):<fpage>934</fpage>&#x02013;<lpage>939</lpage>
<object-id pub-id-type="pmid">11934717</object-id><pub-id pub-id-type="pmid">11934717</pub-id></mixed-citation></ref><ref id="pone.0119762.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Christou</surname><given-names>K</given-names></name>, <name><surname>Markoulis</surname><given-names>N</given-names></name>, <name><surname>Moulas</surname><given-names>AN</given-names></name>, <name><surname>Pastaka</surname><given-names>C</given-names></name>, <name><surname>Gourgoulianis</surname><given-names>KI</given-names></name>
<article-title>Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients</article-title>. <source>Sleep Breath</source>. <year>2003</year>;<volume>7</volume>(<issue>3</issue>):<fpage>105</fpage>&#x02013;<lpage>110</lpage>
<object-id pub-id-type="pmid">14569521</object-id><pub-id pub-id-type="pmid">14569521</pub-id></mixed-citation></ref><ref id="pone.0119762.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Suzuki</surname><given-names>YJ</given-names></name>, <name><surname>Jain</surname><given-names>V</given-names></name>, <name><surname>Park</surname><given-names>AM</given-names></name>, <name><surname>Day</surname><given-names>RM</given-names></name>
<article-title>Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases</article-title>. <source>Free Radic Biol Med</source>. <year>2006</year>;<volume>40</volume>(<issue>10</issue>):<fpage>1683</fpage>&#x02013;<lpage>1692</lpage>
<object-id pub-id-type="pmid">16678006</object-id><pub-id pub-id-type="pmid">16678006</pub-id></mixed-citation></ref><ref id="pone.0119762.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Grebe</surname><given-names>M</given-names></name>, <name><surname>Eisele</surname><given-names>HJ</given-names></name>, <name><surname>Weissmann</surname><given-names>N</given-names></name>, <name><surname>Schaefer</surname><given-names>C</given-names></name>, <name><surname>Tillmanns</surname><given-names>H</given-names></name>, <name><surname>Seeger</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>Antioxidant vitamin C improves endothelial function in obstructive sleep apnea</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2006</year>;<volume>173</volume>(<issue>8</issue>):<fpage>897</fpage>&#x02013;<lpage>901</lpage>
<object-id pub-id-type="pmid">16439717</object-id><pub-id pub-id-type="pmid">16439717</pub-id></mixed-citation></ref><ref id="pone.0119762.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>G</given-names></name>, <name><surname>Peng</surname><given-names>YJ</given-names></name>, <name><surname>Reddy</surname><given-names>VD</given-names></name>, <name><surname>Makarenko</surname><given-names>VV</given-names></name>, <name><surname>Nanduri</surname><given-names>J</given-names></name>, <name><surname>Khan</surname><given-names>SA</given-names></name>, <etal>et al</etal>
<article-title>Mutual antagonism between hypoxia-inducible factors 1&#x003b1; and 2&#x003b1; regulates oxygen sensing and cardio-respiratory homeostasis</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2013</year>;<volume>110</volume>(<issue>19</issue>):<fpage>E1788</fpage>&#x02013;<lpage>1796</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1305961110">10.1073/pnas.1305961110</ext-link></comment><object-id pub-id-type="pmid">23610397</object-id><pub-id pub-id-type="pmid">23610397</pub-id></mixed-citation></ref></ref-list></back></article>